Cargando…
Application of apolipoprotein E-modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain
An innovative drug delivery technology is urgently needed to satisfy unmet medical needs in treating various brain disorders. As a fundamental carrier for plasmid DNA or nucleic acids, we developed a liposomal nanoparticle (multifunctional envelope-type nano device [MEND]) containing a proton-ioniza...
Autores principales: | Tamaru, Mina, Akita, Hidetaka, Nakatani, Taichi, Kajimoto, Kazuaki, Sato, Yusuke, Hatakeyama, Hiroto, Harashima, Hideyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162633/ https://www.ncbi.nlm.nih.gov/pubmed/25228805 http://dx.doi.org/10.2147/IJN.S65402 |
Ejemplares similares
-
In vitro optimization of 2′-OMe-4′-thioribonucleoside–modified anti-microRNA oligonucleotides and its targeting delivery to mouse liver using a liposomal nanoparticle
por: Takahashi, Mayumi, et al.
Publicado: (2013) -
A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant
por: Miura, Naoya, et al.
Publicado: (2015) -
Hepatic Monoacylglycerol O-acyltransferase 1 as a Promising Therapeutic Target for Steatosis, Obesity, and Type 2 Diabetes
por: Hayashi, Yasuhiro, et al.
Publicado: (2014) -
Cytoprotective role of the fatty acid binding protein 4 against oxidative and endoplasmic reticulum stress in 3T3-L1 adipocytes
por: Kajimoto, Kazuaki, et al.
Publicado: (2014) -
Elimination of the biphasic pharmacodynamics of 15d-PGJ2 by controlling its release from a nanoemulsion
por: Abbasi, Saed, et al.
Publicado: (2016)